|
|||||||
|
Rheumatoid arthritis (RA) patients have been treated with several different drugs, including Enbrel (etanercept) and methotrexate. Now a study conducted in the United Kingdom indicates that treatment with a combination of Enbrel (an anti-TNF), and methotrexate increases the remission rate. Nearly 550 RA patients from Europe, Asia, Australia and Latin America, none of whom [...] Earlier this year British researchers raised a concern that anti-TNF drugs, as a result of their action in depressing the immune system, may increase the overall risk of cancer. Spanish researchers who are presenting their research at the American College of Rheumatology’s annual meeting in San Francisco say their studies do not support that conclusion. [...] Researchers are not sure of the exact causes of rheumatoid arthritis (RA), but they have discovered that cytokines (bioactive proteins), in particular TNF-alpha and IL-6 are significant contributors. These cytokines cause inflammation which leads to destruction of the joints and tissues. The action of another cytokine, placenta growth factor (PIGF), is suspected to be [...] A study conducted in 2003 by the University of California, Davis was the first to test for key inflammatory indicators, called markers, in blood samples from healthy people. [...] The first international guidelines for the treatment of psoriatic arthritis has been developed and published by a group of rheumatologists, dermatologists, and patient advocates. [...] |
  
|
||||||
|
Copyright © 2012 Current Arthritis News and Research - All Rights Reserved
|
|||||||
